Skip to main content
. 2023 Aug 1;13(1):116. doi: 10.1038/s41408-023-00879-7

Fig. 1. Risk factors for infection in patients with MM receiving BsAbs.

Fig. 1

BsAb bispecific antibody, CAR-T chimeric antigen receptor T-cell, CMV cytomegalovirus, HBV hepatitis B virus, IMiD immunomodulatory drug, MM multiple myeloma, PI proteasome inhibitors, PS propensity score, VZV varicella zoster virus.